Randomized phase II/III trial assessing gemcitabine/carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: EORTC study 30986 - De Santis, M; Bellmunt, J; Mead, G (J Clin Oncol, 2012)
et al.